Unibest
← Back to patent-cliff list

Anamorelin Hydrochloride

Tier C — Watch / trade

Anamorelin Hydrochloride

-
Originator
2021
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:GHSR

Brand:Adlumiz

Indications (approved):Cachexia

Regional status

US
Phase III
2011-07-01
EU
Phase III
2011-07-01
China
Phase I
2017-09-30
Japan
Approved
2021-01-22

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Anamorelin Hydrochloride?

Approved indications include: Cachexia.

When does the Anamorelin Hydrochloride patent expire?

No public expiry year is available for Anamorelin Hydrochloride yet; this page updates once verified.

How do I get a quote for Anamorelin Hydrochloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-01